Century Therapeutics, Inc.: cash_and_equivalents

Value{"amount": 56878000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Period (as of 2025-06-30)
Statuscurrent
EntityCentury Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001558370-25-011575 · Open the official SEC filing →
Retrieved: 2026-08-19T18:37:50.988586+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001850119/cash-and-equivalents/2025-06-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/96a77b1b-4ded-4d8e-a0b9-e722fbc771e5

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies